Method for making high purity cardiomyocyte preparations suitable for regenerative medicine

Details for Australian Patent Application No. 2005224670 (hide)

Owner Geron Corporation

Inventors Gold, Joseph D.; Hassanipour, Mohammad; Xu, Chunhui; Collins, Lila R.

Agent FB Rice

Pub. Number AU-B-2005224670

PCT Pub. Number WO2005/090558

Priority 10/805,099 19.03.04 US; 60/556,722 26.03.04 US; 60/650,194 03.02.05 US

Filing date 18 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 11 November 2010

International Classifications

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/090558 Priority application(s): WO2005/090558

11 November 2010 Application Accepted

  Published as AU-B-2005224670

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224672-Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast

2005224668-Oil containing starch granules for delivering benefit-additives to a substrate